Vitligo Research Foundation Identifies Drugs for Repurposing to Expedite Vitiligo Therapy Development
Vitiligo Research Foundation (VRF) has identified more than 10 repurposing opportunities for existing drugs in order to expedite therapy development for the neglected disease that affects close to 100 million people worldwide.
View full press release